“School of Cognitive”

Back to Papers Home
Back to Papers of School of Cognitive

Paper   IPM / Cognitive / 13853
School of Cognitive Sciences
  Title:   Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala
  Author(s): 
1.  M. Mohammadi
2.  M. Nasehi
3.  M.R. Zarrindast
  Status:   Published
  Journal: Behavioural Brain Research
  Vol.:  280
  Year:  2015
  Pages:   36-44
  Supported by:  IPM
  Abstract:
AIM: The amygdala is a major target of midbrain dopaminergic neurons and is implicated in learning and memory processes. This study investigates the effect of basolateral amygdale (BLA) dopamine receptors on spatial and non-spatial novelty detection deficit, induced by a selective CB1 cannabinoid receptor agonist (Arachidonylcyclopropylamide; ACPA), during a non-associative task.
METHODS: Male mice weighing 30-35 g were used. Open field procedure was employed to assess the spatial and non-spatial memory retention.
RESULTS: Our data showed that post-training intraperitoneal injection of ACPA (0.02 mg/kg), intra-BLA microinjection of SKF38393 (D1 dopamine receptor agonist; at higher dose, 0.1 μg/mouse) and SCH23390 (D1 dopamine receptor antagonist; at lowest dose, 0.005 μg/mouse) impaired both spatial and non-spatial novelty detection. Moreover, intra-BLA microinjection of subthreshold dose of SKF38393 or SCH23390 restored and potentiated the spatial and non-spatial novelty detection impairment caused by ACPA, respectively.
CONCLUSION: Our results suggested that the ACPA induced impairment of memory retention, may occur through BLA D1 dopamine receptors.

Download TeX format
back to top
scroll left or right